GlassScriptPhysician profile
Matthew G Cusick
NPI 1275743270
$346.38
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.28 · 2021: $247 · 2022: $82.71.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $79.47 | 2021 | |
| Smith+Nephew, INC. | $67.19 | 2021-2022 | |
| Intuitive Surgical, INC. | $59.86 | 2021-2022 | |
| Organogenesis INC. | $40.27 | 2021-2022 | |
| Innocoll Pharmaceuticals Limited | $28.52 | 2021 | |
| Medela LLC | $25.75 | 2021 | |
| Seagen INC. | $16.28 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $15.71 | 2022 | |
| Ethicon US, LLC | $13.33 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cusick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.